Document Detail


Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.
MedLine Citation:
PMID:  21744268     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE AND DESIGN: The peptide from C-terminal domain of MCP-1 (Ingramon) has been shown to inhibit monocyte migration and possess anti-inflammatory activity in animal models of inflammation and post-angioplasty restenosis. Here, we investigate the effect of Ingramon treatment on blood levels of acute-phase reactants and chemokines in patients after coronary stenting and the mechanisms of Ingramon anti-inflammatory activity. SUBJECTS: Eighty-seven patients with ischemic heart disease (IHD) who faced the necessity of coronary angiography (CA) were enrolled. In 67 patients, one-stage coronary stenting was performed; 33 of them were treated with Ingramon in addition to standard therapy. Twenty patients underwent CA only. METHODS: High-sensitivity C-reactive protein (hsCRP) and fibrinogen blood levels were detected routinely. The chemokine concentration in plasma was measured by enzyme-linked immunosorbent assay (ELISA) or cytometric bead array-based immunoassay. Intracellular Ca(2+) levels and cell surface integrin exposure were assayed by flow cytometry. MCP-1 dimerization was studied by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). MCP-1-heparin binding was assessed with a biosensor and ELISA. RESULTS AND CONCLUSIONS: Ingramon treatment was accompanied by less pronounced elevation of hsCRP and fibrinogen levels and decreased MCP-1 concentration in plasma in patients after coronary stenting. Ingramon had no effect on MCP-1 interaction with cell receptors or MCP-1 dimerization, but inhibited MCP-1 binding to heparin. The anti-inflammatory activity of the peptide may be mediated by an impaired chemokine interaction with glycosaminoglycans.
Authors:
T I Arefieva; T L Krasnikova; A V Potekhina; N U Ruleva; P I Nikitin; T I Ksenevich; B G Gorshkov; M V Sidorova; Zh D Bespalova; N B Kukhtina; S I Provatorov; E A Noeva; E I Chazov
Related Documents :
22326848 - Myd88 mediated inflammatory signaling leads to camkii oxidation, cardiac hypertrophy an...
21938018 - Lox-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chroni...
20394588 - Ultrasound measurements of the lateral ventricles in neonates: why, how and when? a sys...
7249658 - Possibilities and limitations of non-invasive techniques for the study of left ventricu...
7741228 - Thallium-201 as an agent for myocardial imaging studies.
3987698 - Computerized analysis of equilibrium radionuclide ventriculography time-activity curve ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-10
Journal Detail:
Title:  Inflammation research : official journal of the European Histamine Research Society ... [et al.]     Volume:  -     ISSN:  1420-908X     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508160     Medline TA:  Inflamm Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Institute of Experimental Cardiology, Russian Cardiology Research and Production Complex of Ministry of Health RF, 3rd Cherepkovskaya str., 15, Moscow, 121552, Russia, arefieva@cardio.ru.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genome-wide gene expression study indicates the anti-inflammatory effect of polarized light in recur...
Next Document:  Experimental investigation of collagen waviness and orientation in the arterial adventitia using con...